In vivo T-depleted reduced-intensity transplantation for GATA2-related immune dysfunction

Blood. 2018 Mar 22;131(12):1383-1387. doi: 10.1182/blood-2017-10-811489. Epub 2018 Jan 2.

Authors

Eleni Tholouli¹, Katherine Sturgess², Rachel E Dickinson², Andrew Gennery^{2

3}, Andrew J Cant^{2

3}, Graham Jackson^{3

4}, Jim Lordan³, Sophie Hambleton^{2

3}, Mary A Slatter³, Venetia Bigley^{2

3}, Matthew Collin^{2

3}

Affiliations

¹ Manchester Royal Infirmary, Manchester, United Kingdom.
² Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
³ Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and.
⁴ Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Abstract

Publisher's Note: There is a Blood Commentary on this article in this issue.

Publication types

Clinical Trial
Letter
Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Allografts
Child
Female
Follow-Up Studies
GATA2 Deficiency / genetics
GATA2 Deficiency / immunology*
GATA2 Deficiency / therapy*
Germ-Line Mutation
Hematopoietic Stem Cell Transplantation*
Humans
Lymphocyte Depletion*
Male
Retrospective Studies
United Kingdom

Grants and funding